InsiderTrades.com logo
We recommended Nvidia in 2016, now we’re recommending this…
From Porter & Company   |   Ad
The AI boom is just getting started. And the real wealth has still to be made…
You must read this new presentation from Porter Stansberry.

Douglas Beck Biography and Net Worth

CFO of Beyond Air
  • LinkedIn
  • Phone
  • Email
  • Website


Douglas J. Beck CPA serves as Chief Financial Officer of the Company. He was the Chief Financial officer of JLM Couture Inc, from February 16 until October 31, 2018, the Chief Financial Officer of Relmada Therapeutics, Inc. from December 2013 and was the Chief Financial Officer for iBio, Inc. from January 2011 to March 2013. In addition, Mr. Beck serves on the New York State Society of CPAs Chief Financial Officer and SEC committee. Mr. Beck is a graduate of Fairleigh Dickinson University and is a licensed certified public accountant in New York.

What is Douglas Beck's net worth?

The estimated net worth of Douglas Beck is at least $11,041.34 as of June 16th, 2021. Mr. Beck owns 22,460 shares of Beyond Air stock worth more than $11,041 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Beck may own. Learn More about Douglas Beck's net worth.

How do I contact Douglas Beck?

The corporate mailing address for Mr. Beck and other Beyond Air executives is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. Beyond Air can also be reached via phone at (516) 665-8200 and via email at [email protected]. Learn More on Douglas Beck's contact information.

Has Douglas Beck been buying or selling shares of Beyond Air?

Douglas Beck has not been actively trading shares of Beyond Air in the last ninety days. Most recently, on Wednesday, June 16th, Douglas Beck bought 1,000 shares of Beyond Air stock. The stock was acquired at an average cost of $5.38 per share, with a total value of $5,380.00. Following the completion of the transaction, the chief financial officer now directly owns 22,460 shares of the company's stock, valued at $120,834.80. Learn More on Douglas Beck's trading history.

Who are Beyond Air's active insiders?

Beyond Air's insider roster includes Amir Avniel (COO), Douglas Beck (CFO), Ron Bentsur (Director), Robert Carey (Director), and Steven Lisi (CEO). Learn More on Beyond Air's active insiders.

Are insiders buying or selling shares of Beyond Air?

In the last year, Beyond Air insiders bought shares 5 times. They purchased a total of 2,893,667 shares worth more than $2,887,792.65. In the last year, insiders at the sold shares 1 times. They sold a total of 11,267 shares worth more than $23,210.02. The most recent insider tranaction occured on September, 26th when CEO Steven A Lisi bought 1,476,626 shares worth more than $738,313.00. Insiders at Beyond Air own 20.1% of the company. Learn More about insider trades at Beyond Air.

Information on this page was last updated on 9/26/2024.

Douglas Beck Insider Trading History at Beyond Air

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/16/2021Buy1,000$5.38$5,380.0022,460View SEC Filing Icon  
12/31/2020Buy3,000$5.28$15,840.0021,460View SEC Filing Icon  
9/24/2020Buy3,000$4.88$14,640.00View SEC Filing Icon  
11/12/2019Buy689$3.98$2,742.2211,960View SEC Filing Icon  
11/8/2019Buy2,250$4.09$9,202.5011,960View SEC Filing Icon  
6/3/2019Buy9,710$5.15$50,006.509,710View SEC Filing Icon  
See Full Table

Douglas Beck Buying and Selling Activity at Beyond Air

This chart shows Douglas Beck's buying and selling at Beyond Air by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Beyond Air Company Overview

Beyond Air logo
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Read More

Today's Range

Now: $0.49
Low: $0.49
High: $0.52

50 Day Range

MA: $0.42
Low: $0.30
High: $0.57

2 Week Range

Now: $0.49
Low: $0.30
High: $2.36

Volume

407,633 shs

Average Volume

634,323 shs

Market Capitalization

$35.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Bill Gates’s Next Big AI Bet: Stargate
From Brownstone Research   |   Ad
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.
I believe we are about to do it again with this new AI project called Stargate